Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
The global Platinum based Cancer Drug market was valued at US$ 1587 million in 2023 and is anticipated to reach US$ 1907 million by 2030, witnessing a CAGR of 2.7% during the forecast period 2024-2030.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.
Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.
Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.
This report aims to provide a comprehensive presentation of the global market for Platinum based Cancer Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Platinum based Cancer Drug.
The Platinum based Cancer Drug market size, estimations, and forecasts are provided in terms of sales quantity (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Platinum based Cancer Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Platinum based Cancer Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of Platinum based Cancer Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Sales, revenue of Platinum based Cancer Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
- ★ What Is The Overall Market Size And Projected Growth Rate Across Global And Regional Segments?
- ★ How Does The Market Size And Growth Outlook Vary Across Major Countries?
- ★ Which Region Or Market Sub-Segment Is Anticipated To Dominate Growth During The Forecast Period?
- ★ What Are The Primary Factors Expected To Drive Market Expansion, And What Challenges May Restrain Growth?
- ★ Which Emerging Technologies And Market Trends Are Shaping The Future Landscape?
- ★ What Are The Most Significant Opportunities Available In The Market?
- ★ Who Are The Leading Manufacturers Actively Participating In The Global Market?
- ★ Which Company Currently Holds The Largest Share Of The Market?
- ★ What Are The Potential Growth Avenues For New Entrants In The Global Market?